Associated Papers
Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Dogan EO et al.
Annals of Neurology, 2025
SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.
McGuinness HY et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry, 2024
Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients.
Bloom AJ et al.
Molecular Neurodegeneration, 2022
Select a paper to view details